Related Experiment Videos
Does lowering of cholesterol levels influence functional properties of large arteries?
M Kool1, F Lustermans, H Kragten
1Department of Pharmacology, Cardiovascular Research Institute Maastricht, University of Limburg, The Netherlands.
Insights
Short-term pravastatin treatment for hypercholesterolaemia did not improve arterial distensibility (DC) or compliance (CC) in large arteries. This suggests that lowering cholesterol levels does not significantly alter haemodynamics or vessel wall properties in these patients.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Vascular Biology
Background:
- Hypercholesterolaemia is a primary risk factor for atherosclerosis and endothelial dysfunction.
- Endothelial dysfunction can lead to increased vascular tone, arterial stiffness, and reduced arterial distensibility (DC) and compliance (CC).
- Lipid-lowering therapy is hypothesized to potentially improve DC and CC.
Purpose of the Study:
- To investigate the effects of pravastatin on haemodynamics, DC, and CC in the common carotid artery (CCA), femoral artery (FA), and brachial artery (BA).
- To assess the impact of lipid-lowering therapy on large artery properties in patients with primary hypercholesterolaemia.
Main Methods:
- A double-blind, placebo-controlled crossover study involving 19 patients with primary hypercholesterolaemia.
- Patients received 8 weeks of pravastatin (40 mg o.d.) or placebo, following an 8-week placebo run-in period and a low-cholesterol diet.
- Haemodynamics, DC, and CC of CCA, FA, and BA were measured, alongside lipid profiles.
Main Results:
- Pravastatin significantly reduced total cholesterol (26%), LDL-C (35%), and triglycerides (16%), with no change in HDL-C.
- No statistically significant changes in diameter, distensibility (DC), or compliance (CC) of the CCA, FA, or BA were observed compared to placebo.
- Pravastatin did not influence blood pressure, heart rate, cardiac function, or systemic vascular resistance.
Conclusions:
- Short-term lipid-lowering therapy with pravastatin does not alter haemodynamics or the vessel wall properties of large arteries in patients with mild to moderate primary hypercholesterolaemia.
- The findings suggest that improvements in arterial distensibility and compliance may require longer treatment durations or different therapeutic approaches.
- Further research is needed to understand the long-term vascular effects of statin therapy.
Abstract:
Hypercholesterolaemia is a risk factor for atherosclerosis and induces endothelial dysfunction. Endothelial dysfunction may increase vascular tone and arterial stiffness and as a consequence may decrease arterial distensibility (DC) and arterial compliance (CC). It is hypothesized that lipid-lowering therapy may enhance DC and CC. Therefore, the present study investigates the effect of lipid-lowering therapy with pravastatin on the haemodynamics, DC and CC of the elastic common carotid artery (CCA), and the muscular femoral (FA) and brachial (BA) arteries in patients with primary hypercholesterolaemia. After an 8-week placebo run-in period with a low-cholesterol diet, 19 patients with total cholesterol concentrations of between 6.5 and 9.0 mmol.l-1 and triglyceride concentrations < 4 mmol.l-1 entered a double-blind placebo controlled crossover study. Patients received pravastatin 40 mg o.d. or placebo, each for 8 weeks. Throughout the study the lipid-lowering diet was continued. With pravastatin, total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides were decreased (total cholesterol 26%, LDL-C 35%, triglycerides 16%), while high-density lipoprotein cholesterol (HDL-C) was not changed. Other laboratory values remained within the normal range. Blood pressure, heart rate, cardiac function and systemic vascular resistance were not influenced by pravastatin. Compared to placebo, diameter, distensibility and compliance of all arteries were not statistically significantly changed with pravastatin. These data suggest that, in patients with mild to moderate primary hypercholesterolaemia, short-term lowering of plasma cholesterol does not alter the haemodynamics and vessel wall properties of large arteries.